Anal Carcinoma — Trials

Anal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

88 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07118176	Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers	active not recruiting	Phase 1	30	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 2, 2026	clinicaltrials
NCT03260023	Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers	active not recruiting	Phase 1 / Phase 2	143	TransgeneINDUSTRY	3	Feb 5, 2026	clinicaltrials